Last updated: February 20, 2024
Sponsor: Taichung Veterans General Hospital
Overall Status: Active - Recruiting
Phase
4
Condition
Hemorrhage
Treatment
Tranexamic acid
Clinical Study ID
NCT06109155
CF23323A
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- adult, cardiac surgery with cardiopulmonary bypass
Exclusion
Exclusion Criteria:
- pregnant
- emergency procedure
- immune compromised
- aortic surgery
- end-stage renal disease
- liver disease
- critical status
- incomplete clinical data
Study Design
Total Participants: 150
Treatment Group(s): 1
Primary Treatment: Tranexamic acid
Phase: 4
Study Start date:
February 08, 2024
Estimated Completion Date:
December 31, 2026
Study Description
Connect with a study center
Taichung Veterans General Hospital
Taichung, 40705
TaiwanActive - Recruiting
Taichung Veterans General hospital
Taichung, 40705
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.